Jonathan P. Miller, M.D., Joins Marcus Neuroscience Institute as Director of Peripheral Nerve and Functional Neurorestoration and Director of Clinical Research

• by

• November 11, 2026

Error in Affiliation

• November 2, 2026

FDA approves first factor XIa stroke drug

In a 12,327-patient trial, asundexian cut recurrent ischemic stroke risk by 26% alongside antiplatelets.

• by Mouj Hijazi

• November 10, 2026

• 3 min

Brain reward responses linked to fat gain

Repeated UPF exposure may heighten responses to food cues, potentially reinforcing eating habits that could contribute to adiposity gain.

• by Andrea Surnit

• November 9, 2026

• 4 min